Скачать или смотреть FDA Approves Delgocitinib for Chronic Hand Eczema | Linda Stein Gold, MD, Reacts

The FDA has approved delgocitinib (Anzupgo) cream, the first-ever treatment specifically for moderate-to-severe chronic hand eczema in adults. In this interview, Linda Stein Gold, MD, a dermatologist at Henry Ford Health, breaks down what this long-awaited approval means for patients and prescribers.

Stein Gold discusses the significant burden of chronic hand eczema, the limitations of previous treatments like topical corticosteroids, and why delgocitinib marks a critical milestone for dermatology.

Read more about the approval here: https://www.hcplive.com/view/linda-st...

Key Timestamps:
00:07: The historic importance of this approval
01:26: How delgocitinib changes the typical treatment approach
03:12: How the trials DELTA 1 and DELTA 2 inform treatment decisions
04:44: The unmet need in chronic hand eczema & where the field is heading

#Delgocitinib #HandEczema #FDAApproval #FDA #Dermatology #EczemaTreatment #SkinHealth